ISIS Financial Facts
Total revenue: 110.93MBasic net loss (in dollars per share): 0.06
See Full Income Statement
Current portion of long-term obligations: 49K
Total current assets: 730.33M
See Full Balance Sheet
Isis Pharmaceuticals, Inc. (ISIS) Earnings
|
Expand Research on ISIS
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +296.6% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +4.5% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/6/12 | Q312 | -$0.37 | -$0.26 | -$0.11 | $11.6M | $23.11M | N/A | Details | |||
11/9/15 | Q315 | -$0.30 | -$0.31 | +$0.01 | $49.1M | $52.93M | N/A | Details | |||
5/6/14 | Q114 | -$0.27 | -$0.23 | -$0.04 | $28.2M | $35.12M | N/A | Details | |||
11/7/11 | Q311 | -$0.27 | -$0.20 | -$0.07 | $20.7M | $25.33M | N/A | Details | |||
5/8/12 | Q112 | -$0.24 | -$0.26 | +$0.02 | $23.2M | $22.72M | N/A | Details | |||
11/7/14 | Q314 | -$0.23 | -$0.20 | -$0.03 | $44.1M | $45.8M | N/A | Details | |||
2/28/14 | Q413 | -$0.21 | -$0.17 | -$0.04 | $42.2M | $34.2M | N/A | Details | |||
11/5/13 | Q313 | -$0.21 | -$0.27 | +$0.06 | $23.6M | $19.82M | N/A | Details |